CLINICAL_TRIALS
research
· 2026-04-16
Clinical Trial Update: Pembrolizumab in Locally Advanced Sinonasal Carcinoma [Phase 2]
Summary
A Phase 2 clinical trial is evaluating pembrolizumab for locally advanced Sinonasal Undifferentiated Carcinoma and is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Istituti Clinici Scientifici Maugeri SpA | Conditions: Sinonasal Undifferentiated Carcinoma | Phase 2 | Status: RECRUITING